PT1729777E - Composição farmacêutica que compreende um sal de mirtazapina - Google Patents
Composição farmacêutica que compreende um sal de mirtazapina Download PDFInfo
- Publication number
- PT1729777E PT1729777E PT05740221T PT05740221T PT1729777E PT 1729777 E PT1729777 E PT 1729777E PT 05740221 T PT05740221 T PT 05740221T PT 05740221 T PT05740221 T PT 05740221T PT 1729777 E PT1729777 E PT 1729777E
- Authority
- PT
- Portugal
- Prior art keywords
- mirtazapine
- salt
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title 1
- 229960001785 mirtazapine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101664 | 2004-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1729777E true PT1729777E (pt) | 2009-04-27 |
Family
ID=34928990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT05740221T PT1729777E (pt) | 2004-04-21 | 2005-04-19 | Composição farmacêutica que compreende um sal de mirtazapina |
Country Status (31)
Country | Link |
---|---|
US (1) | US20070111993A1 (pt) |
EP (1) | EP1729777B1 (pt) |
JP (2) | JP5260959B2 (pt) |
CN (2) | CN101824035A (pt) |
AR (1) | AR049028A1 (pt) |
AT (1) | ATE424210T1 (pt) |
AU (1) | AU2005235383B2 (pt) |
BR (1) | BRPI0509953A (pt) |
CA (1) | CA2561281C (pt) |
CY (1) | CY1109018T1 (pt) |
DE (1) | DE602005013066D1 (pt) |
DK (1) | DK1729777T3 (pt) |
EC (1) | ECSP066938A (pt) |
ES (1) | ES2321961T3 (pt) |
HR (1) | HRP20090190T1 (pt) |
IL (1) | IL178201A (pt) |
LV (1) | LV13556B (pt) |
MX (1) | MXPA06011830A (pt) |
MY (1) | MY144899A (pt) |
NO (1) | NO20065077L (pt) |
NZ (1) | NZ550052A (pt) |
PE (1) | PE20060400A1 (pt) |
PL (1) | PL1729777T3 (pt) |
PT (1) | PT1729777E (pt) |
RS (1) | RS50764B (pt) |
RU (1) | RU2375362C2 (pt) |
SI (1) | SI1729777T1 (pt) |
TW (1) | TW200538100A (pt) |
UA (1) | UA89773C2 (pt) |
WO (1) | WO2005102352A1 (pt) |
ZA (1) | ZA200608305B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
CN104095824B (zh) * | 2013-04-09 | 2016-08-31 | 上海信谊万象药业股份有限公司 | 一种米氮平缓释片及其制备方法 |
PT3261645T (pt) | 2015-02-27 | 2021-06-17 | Dechra Ltd | Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos |
CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US4193828A (en) * | 1976-07-27 | 1980-03-18 | Fiber Materials, Inc. | Method of forming carbon composites |
US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
WO1999051237A1 (en) * | 1998-04-02 | 1999-10-14 | Akzo Nobel N.V. | Oral liquid antidepressant solution |
AU5764900A (en) * | 1999-06-25 | 2001-01-31 | University Of South Florida | Mirtazapine for weight gain in wasting diseases |
US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
WO2001042239A1 (fr) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
PT1242092E (pt) * | 2000-04-05 | 2003-11-28 | Akzo Nobel Nv | Combinacao de farmacos para o tratamento da dor de cabeca que compreende mirtazapina e paracetamol ou um farmaco nao esteroide anti-inflamatorio |
-
2005
- 2005-04-12 TW TW094111559A patent/TW200538100A/zh unknown
- 2005-04-19 RU RU2006140988/04A patent/RU2375362C2/ru not_active IP Right Cessation
- 2005-04-19 UA UAA200610312A patent/UA89773C2/ru unknown
- 2005-04-19 EP EP05740221A patent/EP1729777B1/en active Active
- 2005-04-19 MY MYPI20051731A patent/MY144899A/en unknown
- 2005-04-19 NZ NZ550052A patent/NZ550052A/en unknown
- 2005-04-19 CN CN201010174000A patent/CN101824035A/zh active Pending
- 2005-04-19 DE DE602005013066T patent/DE602005013066D1/de active Active
- 2005-04-19 MX MXPA06011830A patent/MXPA06011830A/es not_active IP Right Cessation
- 2005-04-19 CA CA2561281A patent/CA2561281C/en not_active Expired - Fee Related
- 2005-04-19 PT PT05740221T patent/PT1729777E/pt unknown
- 2005-04-19 US US11/547,152 patent/US20070111993A1/en not_active Abandoned
- 2005-04-19 JP JP2007508904A patent/JP5260959B2/ja not_active Expired - Fee Related
- 2005-04-19 SI SI200530673T patent/SI1729777T1/sl unknown
- 2005-04-19 RS RSP-2009/0164A patent/RS50764B/sr unknown
- 2005-04-19 BR BRPI0509953-6A patent/BRPI0509953A/pt not_active IP Right Cessation
- 2005-04-19 CN CN2005800116628A patent/CN1942191B/zh not_active Expired - Fee Related
- 2005-04-19 ES ES05740221T patent/ES2321961T3/es active Active
- 2005-04-19 AU AU2005235383A patent/AU2005235383B2/en active Active
- 2005-04-19 PL PL05740221T patent/PL1729777T3/pl unknown
- 2005-04-19 AT AT05740221T patent/ATE424210T1/de active
- 2005-04-19 DK DK05740221T patent/DK1729777T3/da active
- 2005-04-19 WO PCT/EP2005/051714 patent/WO2005102352A1/en active Application Filing
- 2005-04-20 PE PE2005000439A patent/PE20060400A1/es not_active Application Discontinuation
- 2005-04-20 AR ARP050101549A patent/AR049028A1/es unknown
-
2006
- 2006-09-20 IL IL178201A patent/IL178201A/en not_active IP Right Cessation
- 2006-10-05 ZA ZA200608305A patent/ZA200608305B/xx unknown
- 2006-10-19 EC EC2006006938A patent/ECSP066938A/es unknown
- 2006-11-03 NO NO20065077A patent/NO20065077L/no not_active Application Discontinuation
- 2006-11-21 LV LVP-06-130A patent/LV13556B/lv unknown
-
2009
- 2009-03-31 HR HR20090190T patent/HRP20090190T1/xx unknown
- 2009-05-05 CY CY20091100481T patent/CY1109018T1/el unknown
-
2013
- 2013-03-08 JP JP2013046645A patent/JP2013136626A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200606229B (en) | A pharmaceutical composition | |
IL182614A0 (en) | Pharmaceutical compounds | |
IL177480A0 (en) | Pharmaceutical composition | |
EP1765283A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
EP1776112A4 (en) | HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS | |
IL182703A0 (en) | Pharmaceutical compositions comprising a camtothecin derivative | |
IL181229A0 (en) | Noncardiotoxic pharmaceutical compounds | |
EP1805154A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
ZA200608305B (en) | Pharmaceutical composition comprising a salt of mirtazapine | |
HU0401177D0 (en) | Pharmaceutical composition | |
GB2411355B (en) | Pharmaceutical composition | |
GB0400452D0 (en) | A pharmaceutical composition | |
ZA200701932B (en) | Pharmaceutical composition | |
GB0425255D0 (en) | Pharmaceutical composition | |
ZA200701931B (en) | Pharmaceutical composition | |
EP1716865A4 (en) | PHARMACEUTICAL PREPARATION CONTAINING PARAOXONASE | |
PL373776A1 (en) | Oral pharmaceutical compound | |
EP1747205A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
GB0428554D0 (en) | Pharmaceutical compounds | |
GB0424742D0 (en) | Pharmaceutical compounds | |
GB0400971D0 (en) | Pharmaceutical compositions | |
GB0407351D0 (en) | Pharmaceutical compositions | |
GB0402799D0 (en) | Pharmaceutical composition | |
GB0411382D0 (en) | Pharmaceutical compounds | |
GB0412894D0 (en) | Pharmaceutical compounds |